Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-08 Sale | 2026-04-10 4:33 pm | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 85,163 | $40.1 | $3,415,036 | 244,882 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 5:13 pm | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 9,911 | $37.37 | $370,411 | 112,018 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 5:11 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 10,612 | $37.37 | $396,610 | 137,101 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 5:05 pm | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 21,981 | $37.37 | $821,513 | 1,382,983 (Indirect Direct) | View |
| 2026-03-12 Sale | 2026-03-13 5:46 pm | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 5,000 | $36.15 | $180,761 | 16,300 (Direct) | View |
| 2026-03-03 Sale | 2026-03-04 5:44 pm | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 3,000 | $39.67 | $119,010 | 13,300 (Direct) | View |
| 2026-03-03 Sale | 2026-03-04 5:43 pm | Crinetics Pharmaceuticals Inc. | CRNX | Schilke Tobin Chief Financial Officer | 6,713 | $39.67 | $266,305 | 78,121 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 5:11 pm | Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer | 2,500 | $55 | $137,500 | 98,334 (Direct) | View |
| 2025-12-01 Sale | 2025-12-03 4:28 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $45.02 | $225,100 | 135,879 (Direct) | View |
| 2025-11-03 Sale | 2025-11-05 5:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $42.66 | $213,312 | 140,312 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:41 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $41.81 | $209,050 | 145,312 (Direct) | View |
| 2025-09-26 Sale | 2025-09-30 4:42 pm | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 4,000 | $45 | $180,000 | 1,298,222 (Indirect Direct) | View |
| 2025-09-26 Sale | 2025-09-30 4:41 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 16,000 | $44.75 | $716,000 | 24,928 (Direct) | View |
| 2025-09-02 Sale | 2025-09-04 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $32.1 | $160,500 | 180,312 (Direct) | View |
| 2025-08-22 Sale | 2025-08-26 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 30,000 | $30.43 | $912,900 | 155,312 (Direct) | View |
| 2025-08-20 Sale | 2025-08-21 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 6,492 | $29.18 | $189,437 | 66,270 (Direct) | View |
| 2025-06-12 Sale | 2025-06-16 4:48 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 97,483 | $32.23 | $3,141,877 | 266,425 (Direct) | View |
| 2025-03-19 Sale | 2025-03-21 6:34 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 2,515 | $34.2 | $86,021 | 72,233 (Direct) | View |
| 2025-03-19 Sale | 2025-03-21 6:33 pm | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 7,162 | $34.2 | $244,964 | 87,491 (Direct) | View |
| 2025-03-19 Sale | 2025-03-21 6:32 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 5,770 | $34.2 | $197,353 | 108,588 (Direct) | View |
| 2025-03-19 Sale | 2025-03-21 6:31 pm | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 17,338 | $34.2 | $593,017 | 1,220,952 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-08 Exercise | 2026-04-10 4:33 pm | N/A 2031-09-01 | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 78,434 | $0 | 244,882 (Direct) | View |
| 2026-04-08 Exercise | 2026-04-10 4:33 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 9,624 | $20.02 | 244,882 (Direct) | View |
| 2026-04-08 Exercise | 2026-04-10 4:33 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 49,474 | $23.98 | 244,882 (Direct) | View |
| 2026-04-08 Exercise | 2026-04-10 4:33 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Dev. & Operating Officer | 19,336 | $19.64 | 244,882 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:37 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 290,000 | $0 | 1,632,964 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:36 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Schilke Tobin Chief Financial Officer | 82,000 | $0 | 134,834 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:34 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 89,000 | $0 | 176,929 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:34 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 77,000 | $0 | 194,713 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:32 pm | N/A 2036-02-23 | Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer | 89,000 | $0 | 89,834 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-07 5:11 pm | N/A 2035-01-10 | Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer | 2,500 | $0 | 98,334 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-07 5:11 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer | 2,500 | $40.59 | 98,334 (Direct) | View |
| 2025-12-26 Exercise | 2025-12-29 4:36 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 18,000 | $0 | 208,227 (Direct) | View |
| 2025-12-26 Exercise | 2025-12-29 4:36 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 18,000 | $1.91 | 208,227 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:54 pm | N/A 2028-05-24 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 44,742 | $0 | 1,602,022 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:54 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 16,342 | $9.28 | 1,602,022 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:54 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 28,400 | $15.29 | 1,602,022 (Direct) | View |
| 2025-12-01 Exercise | 2025-12-03 4:28 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $0 | 135,879 (Direct) | View |
| 2025-12-01 Exercise | 2025-12-03 4:28 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $16.89 | 135,879 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-05 5:00 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $0 | 140,312 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-05 5:00 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $16.89 | 140,312 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:41 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $0 | 145,312 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:41 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $16.89 | 145,312 (Direct) | View |
| 2025-09-26 Exercise | 2025-09-30 4:41 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 10,000 | $0 | 24,928 (Direct) | View |
| 2025-09-26 Exercise | 2025-09-30 4:41 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 10,000 | $1.91 | 24,928 (Direct) | View |
| 2025-09-02 Exercise | 2025-09-04 4:30 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $0 | 180,312 (Direct) | View |
| 2025-09-02 Exercise | 2025-09-04 4:30 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 5,000 | $16.89 | 180,312 (Direct) | View |
| 2025-08-22 Exercise | 2025-08-26 4:30 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 30,000 | $0 | 155,312 (Direct) | View |
| 2025-08-22 Exercise | 2025-08-26 4:30 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 30,000 | $16.89 | 155,312 (Direct) | View |
| 2025-06-12 Exercise | 2025-06-16 4:48 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 88,170 | $0 | 266,425 (Direct) | View |
| 2025-06-12 Exercise | 2025-06-16 4:48 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 71,525 | $1.91 | 266,425 (Direct) | View |
| 2025-06-12 Exercise | 2025-06-16 4:48 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 16,645 | $9.28 | 266,425 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:30 pm | N/A 2035-06-11 | Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director | 17,250 | $0 | 26,650 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:30 pm | N/A 2035-06-11 | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 17,250 | $0 | 26,650 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:30 pm | N/A 2035-06-11 | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 17,250 | $0 | 31,650 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:30 pm | N/A 2035-06-11 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 17,250 | $0 | 39,186 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:30 pm | N/A 2035-06-11 | Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director | 17,250 | $0 | 26,650 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:30 pm | N/A 2035-06-11 | Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director | 17,250 | $0 | 26,650 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:30 pm | N/A 2035-06-11 | Crinetics Pharmaceuticals Inc. | CRNX | WIERENGA WENDALL Director | 17,250 | $0 | 126,496 (Direct) | View |
| 2025-05-14 Gift | 2025-05-16 4:30 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 90,400 | $0 | 1,302,222 (Direct) | View |
| 2025-04-02 Exercise | 2025-04-04 4:30 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 81,270 | $0 | 1,302,222 (Direct) | View |
| 2025-04-02 Exercise | 2025-04-04 4:30 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 81,270 | $1.91 | 1,302,222 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-11 4:30 pm | N/A 2035-03-09 | Crinetics Pharmaceuticals Inc. | CRNX | Schilke Tobin Chief Financial Officer | 132,000 | $0 | 132,000 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-24 4:30 pm | N/A 2035-02-19 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 402,000 | $0 | 1,551,290 (Direct) | View |